Your session is about to expire
← Back to Search
Cycled Phototherapy for Premature Infants
Study Summary
This trial suggests that for very premature infants, cycled phototherapy (PT) is better than continuous PT in terms of survival.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have undergone phototherapy before.The infant is very sick and may not survive much longer. The doctors have recommended limiting or stopping care, or the parents have asked to stop care. The infant's blood is not carrying enough oxygen and their heart rate is too slow for more than two hours.The study does not include newborn babies.My baby is between 12 to 36 hours old.I have a condition that breaks down my red blood cells.My infant was enrolled after 36 hours of age.I have a viral or fungal infection.You have a significant birth defect or abnormality.
- Group 1: Continuous Phototherapy
- Group 2: Cycled Phototherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Where are the test sites for this clinical trial?
"There are 15 enrolling patients for this study such as University of Rochester in Rochester, University of Texas Southwestern Medical Center at Dallas in Dallas, and Brown University - Women and Infants Hospital of Rhode island in Providence,to name a few 15 other locations."
Can patients that are over 30 years old join this clinical trial?
"This study is currently enrolling patients that are under 27 weeks old and over 22 weeks old."
Are there any studies that show the safety of using light therapy?
"Since this is a phase 3 trial, meaning that there is evidence of efficacy and multiple rounds of data supporting safety, we believe that the safety of phototherapy lights is a 3."
Are they looking for more individuals to participate in this clinical trial at the moment?
"The given data from clinicaltrials.gov tells us that this clinical trial is still looking for eligible patients to participate. The trial was first posted on 7/15/2020, with the most recent update being 9/26/2022."
Could I qualify to enroll in this research?
"1700 infants suffering from hyperbilirubinemia and aged between 22 and 27 weeks old can be admitted into this clinical trial. Most notably, applicants should meet the following criteria: Infants is inborn, Infant is ≤ 750 grams at birth and/or < 27 weeks gestation at birth by best OB estimate, Infant is 12-36 hours of age."
Share this study with friends
Copy Link
Messenger